Skip to main content

Table 1 Summary of basic clinical and FAP IHC information of the cohort of 15 malignant gliomas

From: Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma

Sample Number

Pathology

Primary vsersu recurrent

IDH1 Status

Perivascular FAP

Parenchymal FAP

MGG7

GBM

Primary

Wild type

++

MGG8

GBM

Primary

Wild type

++

MGG63

GBM

Recurrent

Wild type

+

MGG65

GBM

Primary

Wild type

++

MGG66

GBM

Primary

Wild type

+

MGG67

GBM

Primary

Wild type

+

MGG81

GBM

Primary

Mutant

+

MGG90

GBM

Primary

Wild type

++

MGG100

GBM

Primary

Wild type

+

MGG125

GBM

Primary

Wild type

+

+

MGG153

GBM

Primary

Wild type

+

+

MGG162

AA

Primary

Mutant

+

MGG168

GBM

Recurrent

Wild type

+

MGG169

GBM

Primary

Wild type

+

MGG225

GBM

Primary

Wild type

+

+

  1. GBM, glioblastoma; AA, anaplastic astrocytoma; −, negative, +, 2% or less; ++, 2–10%